Locations:
This single-port option offers advantages for appropriate patients
Expert recommendations introduce use of targeted agents
Large-scale database also reveals potential for immunotherapy to protect against cancer
Findings may help guide discussions around prognosis and allogeneic stem cell transplantation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone
New guidelines empower clinicians with practical diagnostic framework
Phase 1 trial outcomes offer encouraging news for developing targeted therapy for solid tumors
Cleveland Clinic to administer first-of-its-kind T-cell therapy
Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy
Best practices for supporting patients with honesty and compassion
Advertisement
Advertisement
Search